Isatuximab
Products in Health Canada’s databases that list Isatuximab as a medicinal or active ingredient, under this spelling. The same substance can be listed under another name (a salt, a common name), which has its own page.
- Drug products
- 3
- 3 authorized now
- Natural health products
- 0
- 0 active licences
- Notices of Compliance
- 12
- Products in all
- 3
Drug products
Authorized products first.
| Name | DIN | Status | Holder | Status since |
|---|---|---|---|---|
| SARCLISA (100 MG) | 02498235 | Marketed | Sanofi-Aventis Canada Inc. | |
| SARCLISA (500 MG) | 02498243 | Marketed | Sanofi-Aventis Canada Inc. | |
| SARCLISA SC (1400 MG) | 02571498 | Approved | Sanofi-Aventis Canada Inc. |
Notices of Compliance
Approvals of drug submissions that list it, newest first.
- SARCLISA SCSeptember 15, 2026 · NOC 38284
- SARCLISAJune 10, 2026 · NOC 37684
- SARCLISAApril 17, 2025 · NOC 35232
- SARCLISAJanuary 31, 2025 · NOC 34773
- SARCLISAJanuary 12, 2024 · NOC 32515
- SARCLISAJanuary 10, 2024 · NOC 32501
- SARCLISAAugust 10, 2023 · NOC 31395
- SARCLISAMay 11, 2023 · NOC 30707
- SARCLISAOctober 12, 2022 · NOC 29184
- SARCLISASeptember 13, 2021 · NOC 26641
- SARCLISAMay 5, 2021 · NOC 25799
- SARCLISAApril 29, 2020 · NOC 23530